TetraGraph in Rocuronium Infusions
Completed · Not applicable
Conditions studied: Surgery
In brief
This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.
Key facts
- Study ID
- NCT06472284
- Run by
- Joseph D. Tobias
- People needed
- 50
- Starts
- 2024-09-12
- Expected to finish
- 2025-04-24
- Last updated by the study team
- 2026-05-13
Who can join
Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients less than 18 years of age
- American Society of Anesthesiologists classification (ASA) 1-4
- Patients undergoing a surgical procedure with general anesthesia and requiring the continuous administration of rocuroniuim
You may not qualify if…
- Patients less than 28 days old
- Patients with history of a progressive or degenerative peripheral neurologic or neuropathic disorder
- Patients undergoing a surgical procedure in which neuromuscular blockade is not required
- Edematous patients
Where it is running
- Nationwide Children's Hospital — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.